The Action of Chinese Medicinal Herbs on Prostate Cancer

中药对前列腺癌的作用

基本信息

  • 批准号:
    7034553
  • 负责人:
  • 金额:
    $ 3.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-03-16 至 2006-09-14
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chinese herbal medicines have been widely used in the world. However, the efficacy and mechanisms of these herbal medicines are not well studied. It is imperative to investigate their efficacy using standardized design, and to elucidate the mechanisms of their action using modern technology. By employing an anti-tumor Chinese herbal formula, ZYD88, the current research proposal is designed to test the hypothesis that ZYD88 induces apoptosis in prostate cancer cells in a xenograft animal model with prostate LNCaP tumor. Cell apoptosis will be determined by assaying caspase-3 activation and CK18, the common early apoptotic events, and DNA fragmentation, a hallmark of cell apoptosis in tumor tissue sections. Furthermore, the release of cytochrome c from mitochondria to cytosol and the cellular levels of Bcl-2 family proteins (Bcl-2, BcI-XL, Bax and Bak), events in apoptotic pathway will be determined by Western blotting analysis. The data will be compared between ZYD88 treated and untreated samples. Dose-response and time-course analyses of ZYD88 action will be performed. These studies will facilitate our understanding of the efficacy and mechanisms of Chinese herbal medicine in cancer therapy, a goal of my career.
说明(申请人提供):中草药已在世界上得到广泛应用。然而,这些中草药的疗效和作用机制还没有得到很好的研究。必须使用标准化设计来研究它们的疗效,并利用现代技术来阐明它们的作用机制。通过使用抗肿瘤中药配方ZYD88,本研究方案旨在验证ZYD88诱导前列腺癌LNCaP肿瘤移植动物模型中前列腺癌细胞凋亡的假说。细胞凋亡将通过检测caspase-3激活和CK18(常见的早期凋亡事件)和DNA片段化(肿瘤组织切片中细胞凋亡的标志)来确定。此外,还将通过Western blotting分析细胞色素c从线粒体向胞浆的释放,以及细胞中Bcl2家族蛋白(Bcl2、Bc1-xl、Bax和Bak)的水平,以及细胞凋亡途径中的事件。将ZYD88处理的样品和未处理的样品进行数据比较。将进行ZYD88作用的剂量-反应和时间-过程分析。这些研究将有助于我们了解中草药在癌症治疗中的疗效和机制,这是我的职业生涯目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAN-WEN DUAN其他文献

YAN-WEN DUAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAN-WEN DUAN', 18)}}的其他基金

The Action of Chinese Medicinal Herbs on Prostate Cancer
中药对前列腺癌的作用
  • 批准号:
    7287969
  • 财政年份:
    2005
  • 资助金额:
    $ 3.05万
  • 项目类别:
The Action of Chinese Medicinal Herbs on Prostate Cancer
中药对前列腺癌的作用
  • 批准号:
    6834758
  • 财政年份:
    2005
  • 资助金额:
    $ 3.05万
  • 项目类别:
The Action of Chinese Medicinal Herbs on Prostate Cancer
中药对前列腺癌的作用
  • 批准号:
    7209753
  • 财政年份:
    2005
  • 资助金额:
    $ 3.05万
  • 项目类别:

相似海外基金

Complementary and alternative medicine for drug-induced gingival overgrowth: inhibitory effect of TRPA1 channel by lutein
药物性牙龈增生的补充和替代医学:叶黄素对 TRPA1 通道的抑制作用
  • 批准号:
    23K09321
  • 财政年份:
    2023
  • 资助金额:
    $ 3.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Complementary alternative medicine contributes to attenuate orofacial pain: anesthetic and anti-inflammatory effects of phytochemical
补充替代医学有助于减轻口面部疼痛:植物化学物质的麻醉和抗炎作用
  • 批准号:
    22K10232
  • 财政年份:
    2022
  • 资助金额:
    $ 3.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Negotiating distinctions between conventional and alternative medicine in the English- and French-language Wikipedias
英语和法语维基百科中讨论传统医学和替代医学之间的区别
  • 批准号:
    AH/V013203/1
  • 财政年份:
    2021
  • 资助金额:
    $ 3.05万
  • 项目类别:
    Research Grant
Systematic study on legal regulations for complementary and alternative medicine
补充替代医学法律法规的系统研究
  • 批准号:
    19K21680
  • 财政年份:
    2019
  • 资助金额:
    $ 3.05万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Contribution of complementary alternative medicine to the orthodontic tooth-movement induced inflammatory pain: a possible role of dietary constituent
补充替代医学对正畸牙齿移动引起的炎症性疼痛的贡献:饮食成分的可能作用
  • 批准号:
    19K10415
  • 财政年份:
    2019
  • 资助金额:
    $ 3.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Application of complementary and alternative medicine for breast cancer based on kinetic characteristics of food components
基于食物成分动力学特征的乳腺癌补充替代医学应用
  • 批准号:
    18K14416
  • 财政年份:
    2018
  • 资助金额:
    $ 3.05万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the Mechanism of Care Effectiveness Using Complementary and Alternative Medicine Material Detergent for Radiation Skin Damage
阐明补充和替代药物材料清洁剂对放射性皮肤损伤的护理效果机制
  • 批准号:
    18K17460
  • 财政年份:
    2018
  • 资助金额:
    $ 3.05万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Quality of clinical research papers on complementary and alternative medicine: evaluation with modified systematic reviews
补充和替代医学临床研究论文的质量:用修改后的系统评价进行评估
  • 批准号:
    17K08938
  • 财政年份:
    2017
  • 资助金额:
    $ 3.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Formulation for the Application of the Energy Therapy "Reiki" as Complementary and Alternative Medicine for Cancer Patient
应用能量疗法“灵气”作为癌症患者的补充和替代医学的配方
  • 批准号:
    16K15906
  • 财政年份:
    2016
  • 资助金额:
    $ 3.05万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Boundaries between Orthodox Medicine and Alternative Medicine
正统医学与替代医学之间的界限
  • 批准号:
    16K21422
  • 财政年份:
    2016
  • 资助金额:
    $ 3.05万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了